View in EDS HTML Full Text PDF Full Text

GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA).

Saved in:
Bibliographic Details
Title: GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA).
Authors: Katzdobler S; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany.; Graduate School of Systemic Neurosciences (GSN), Munich, Germany., Nübling G; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany., Klietz M; Department of Neurology, Hanover Medical School, Hanover, Germany., Fietzek UM; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany., Palleis C; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany., Bernhardt AM; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany.; Clinical Mass Spectrometry Center Munich, Munich, Germany., Wegner F; Department of Neurology, Hanover Medical School, Hanover, Germany., Huber M; Department of Neurology, Hanover Medical School, Hanover, Germany., Rogozinski S; Department of Neurology, Hanover Medical School, Hanover, Germany., Schneider LS; Department of psychiatry and neuroscience, Charité-Universitätsmedizin Berlin, Berlin, Germany., Spruth EJ; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.; Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany., Beyle A; Department of Neurology, University of Bonn, Bonn, Germany., Vogt IR; German Center for Neurodegenerative Diseases (DZNE), Bonn, Bonn, Germany., Brandt M; German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany.; Department of Neurology, Technische Universität Dresden, Dresden, Germany., Hansen N; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany., Glanz W; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.; Institute of Cognitive Neurology and Dementia Research, Otto-Von-Guericke University, Magdeburg, Germany.; Clinic for Neurology, Medical Faculty, University Hospital Magdeburg, Magdeburg, Germany., Brockmann K; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Spottke A; Department of Neurology, University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), Bonn, Bonn, Germany., Hoffmann DC; German Center for Neurodegenerative Diseases (DZNE), Bonn, Bonn, Germany., Peters O; Department of psychiatry and neuroscience, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany., Priller J; Department of Psychiatry and Psychotherapy, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Neuropsychiatry Unit and Laboratory of Molecular Psychiatry, Charité, Universitätsmedizin Berlin and DZNE, Berlin, Germany.; Centre for Clinical Brain Sciences, UK Dementia Research Institute at the University of Edinburgh, University of Edinburgh, Edinburgh, UK., Wiltfang J; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany.; Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal., Düzel E; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.; Institute of Cognitive Neurology and Dementia Research, Otto-Von-Guericke University, Magdeburg, Germany.; Institute of Cognitive Neuroscience, University College London, London, UK., Schneider A; German Center for Neurodegenerative Diseases (DZNE), Bonn, Bonn, Germany.; Dept. of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry, University of Bonn Medical Center, Bonn, Germany., Falkenburger B; German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany.; Department of Neurology, Technische Universität Dresden, Dresden, Germany., Klockgether T; Department of Neurology, University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), Bonn, Bonn, Germany., Gasser T; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Nuscher B; Chair of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), LMU Munich, Munich, Germany., Haass C; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany.; Chair of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), LMU Munich, Munich, Germany., Höglinger G; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Guenter.Hoeglinger@med.uni-muenchen.de.; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. Guenter.Hoeglinger@med.uni-muenchen.de.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany. Guenter.Hoeglinger@med.uni-muenchen.de., Levin J; Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Johannes.levin@med.uni-muenchen.de.; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. Johannes.levin@med.uni-muenchen.de.; German Center for Neurodegenerative Diseases, DZNE, Munich, Germany. Johannes.levin@med.uni-muenchen.de.; Graduate School of Systemic Neurosciences (GSN), Munich, Germany. Johannes.levin@med.uni-muenchen.de.; Clinical Mass Spectrometry Center Munich, Munich, Germany. Johannes.levin@med.uni-muenchen.de.
Source: Journal of neurology [J Neurol] 2024 Oct; Vol. 271 (10), pp. 6991-6999. Date of Electronic Publication: 2024 Sep 10.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-1459
DOI:10.1007/s00415-024-12647-z